217 filings
Page 4 of 11
8-K
jkyorin iyexa
26 Jun 17
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am
8-K
0xmb32sz
2 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
pcotm9s0 zxttre
4 May 17
Endologix Reports First Quarter 2017 Financial Results
12:00am
8-K
gdqob z80a
5 Apr 17
Entry into a Material Definitive Agreement
12:00am
8-K
6eotuyg4yuavc
7 Mar 17
Departure of Directors or Certain Officers
12:00am
8-K
9qs65ef9zqrxf7v
22 Feb 17
Endologix Reports Results for the Fourth Quarter
12:00am
8-K
le8kjiihtesijv5e45
7 Feb 17
Endologix Announces Appointment of Dan Lemaitre as Chairman of the Board
12:00am
8-K
rngkw r7rfd20hu
6 Jan 17
Departure of Directors or Certain Officers
12:00am
8-K
t76rwortmmkvs
13 Dec 16
Other Events
12:00am
8-K
w3oqfx y06q
1 Nov 16
Endologix Reports Results for the Third Quarter 2016
12:00am
8-K
0jc 8rntsrvidwi
2 Aug 16
Endologix Reports Results for the Second Quarter 2016
12:00am
8-K
iiv6ask3f tlen
7 Jun 16
Departure of Directors or Certain Officers
12:00am
8-K
ro5hjktnmi
9 May 16
Endologix Reports Results for the First Quarter 2016
12:00am
8-K/A
q6v4 kfxgh6hwk7ogs0
8 Apr 16
Report of Independent Registered Public Accounting Firm
12:00am
8-K
t5htxrxwyk2
22 Feb 16
Endologix Reports Results for the Fourth Quarter and Full Year 2015
12:00am
8-K
xiy8lytef2l 2v00eafq
11 Feb 16
Departure of Directors or Certain Officers
12:00am
8-K
rwu8qvx84k ekg41req
3 Feb 16
Endologix, Inc. and TriVascular Technologies, Inc. Complete Merger
12:00am
8-K
9zub90 egin
2 Nov 15
Entry into a Material Definitive Agreement
12:00am
8-K
tird rdnkou5gh3dra2h
29 Oct 15
Endologix Announces Proposed $150 Million Convertible Senior Notes Offering
12:00am
8-K
0iywagva9ekd0mt5j
26 Oct 15
Will Expand U.S. and European Sales Organizations to Enhance Growth and Provide Excellent Clinical Support
12:00am